Background: Actinic cheilitis (AC) is a common, chronic premalignant condition re-
| INTRODUC TI ON
Actinic cheilitis (AC) is the mucosal equivalent of the much more prevalent cutaneous actinic keratosis. 1 The term "cheilitis" implies inflammation and therefore is a misnomer, as inflammation is common but not mandatory for the diagnosis, and a more accurate term would therefore be "solar cheiliosis." 2 Nevertheless, AC is still the most widely used term. The vast majority of cases (90%-100%) occur on the lower lip, specifically at the vermilion border, the transition zone between the buccal mucosa and the skin. 3 A white, scaly plaque with a sandpapery feel on palpation is the most common presentation of AC, though other manifestations (such as vermilion border atrophy, erosions, and ulcerations) might also occur. 4 The exact prevalence of this condition is unknown. Available data refers to the prevalence of squamous cell carcinoma (SCC) on the lower lip. In the United States, it is estimated there are 3500 new case of lip cancer every year, 90% of whom are SCC. 5 The literature reports a highly heterogeneous risk of developing cutaneous SCC from AK, ranging from less than 1% to more than 10%. 6 The likelihood that AC would progress to SCC is believed to be greater than SCC developing from cutaneous AK, yet exact statistics are unavailable.
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The etiology is mainly related to chronic ultraviolet (UV) exposure and to factors enhancing the risk for those exposures, such as lower Fitzpatrick skin photo-types, age, and occupation, leisure activities involving prolonged sun exposure, geographic latitude of residence, male gender, not using lip protective agents, genetic predisposition, and immunosuppression. Fortunately, a few decades of solar exposure are usually required for AC to progress to lip SCC, 9 and therefore, early diagnosis and treatment of AC offer a high probability of preventing progression to lip SCC. 
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The aim of this study was to present our clinical experience in the treatment of AC with daylight PDT.
| ME THODS
This is a retrospective study. We exposed the patients to sunlight in the hospital garden between 8 and 11 pm for 2.5 hours, and then instructed them to remain indoors, the rest of the day, in order to prevent further light exposure.
In cases when additional treatments were required, patients were able to choose whether to self-treat at home, or have the treatments performed in a hospital.
The study was approved by the ethics committee of Rabin Medical Center (RMC-0029-18).
| Statistical analysis
Data were analyzed using descriptive statistics. Categorical variables are presented as number and percent, and continuous variables as mean and standard deviation (SD) or median and range. 
| RE SULTS

| Patients
| PDT treatment
All patients underwent repeated treatment sessions every 2-4 weeks until clinical remission was achieved (Figure 1 ) or considered improbable (in patient number 7) using only PDT. The median followup period was 30 months (range 6-60 months). Cure rate was 91% and is the only patient who did not experience complete remission. Table 2 summarizes the PDT sessions and follow-up period for the different patients.
Side effects were mild and included mild erythema (all patients), mild pain during the procedure (four patients) and slight edema lasting less than 48 hours after the procedure (four patients).
| D ISCUSS I ON
Actinic cheilitis is a premalignant condition, with the potential to develop into invasive SCC. 2 Surgical vermilionectomy is the gold standard of treatment, 11 yet it requires high surgical skills, is related to substantial patients' morbidity and the esthetic outcome might be disappointing. 24 Other treatment modalities exist yet none is perfect, as they either lack sufficient clinical efficacy or cause substantial side effects.
Photodynamic therapy is a relatively novel intervention for AC, first reported by Alexiades-Armenakas and Geronemus. 25 Since then, several publications have demonstrated the efficacy of this modality for the treatment of AC. [19] [20] [21] [22] A recent publication demonstrated limited efficacy in 16 patients treated with conventional PDT, however, the patients only underwent two PDT sessions. 26 Based on our data, we suggest that many patients require more than two sessions to achieve remission, thus there is a need to simplify the procedure and reduce costs. The procedure could be significantly simplified by performing daylight PDT, in which the sun serves as the light source instead of an artificial and expensive lamp. This novel approach was
shown to be effective in treating cutaneous lesions. 23 The utilization of daylight PDT not only saves time and money, it also substantially reduces pain during the procedure, by altering the release of accumulated PPIX instead of suddenly releasing high amounts of PpIX, a continuous consumption of PPIX takes place. and 211 J/cm 2 from July through December. 30 Thus, we were able to perform daylight PDT on nearly all days throughout the year.
Only two reports are available in the literature describing treating AC with daylight PDT. The first is the preliminary experience of part of our group in two cases with histological clearance after 3-4 treatment sessions. 31 A second publication by Fai et al reports a retrospective chart review of ten patients treated by daylight PDT for AC: 3 months after the procedure 7 of 10 patients (70%) obtained a complete response, which was maintained in five patients over an observational period of 6-12 months. 32 Our current study demonstrates clinical (and for some patients also histologic) remission in 10 of 11 patients (91%) with minimal side effects. Furthermore, patients were enabled to perform treatment in the comfort of their own homes (after demonstrating competence at least once), without hampering the procedure efficacy, thus demonstrating the procedure's simplicity.
Our study's main limitations include a relatively small sample size and a retrospective design.
| CON CLUS ION
Daylight PDT is effective for the treatment of AC. Although additional studies are indicated with higher numbers of patients and longer follow-up periods, this study provides encouraging support toward providing home treatment for AC.
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